SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indraprastha Medical Corp informs about closure of trading window

24 Dec 2022 Evaluate
Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, Indraprastha Medical Corp has informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and nine months ending 31st December, 2022. The date of the Board Meeting to consider the un-audited financial results for the quarter and nine months ending 31st December, 2022, shall be intimated separately.

The above information is a part of company’s filings submitted to BSE.

Indraprastha Medical Share Price

424.60 -14.40 (-3.28%)
13-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×